Besides iCCA, FGF1 sustains the survival of dormant cancer cells in breast cancer, modulates senescence-associated malignancy in prostate cancer, and reactivates RAF-MEK signaling in pancreatic ductal adenocarcinoma to bypass targeted inhibition [48–50]. This evidence concerns the gene FGF1 and breast carcinoma.